Lupin receives Euro 20 million from Laboratories Servier of France
Mumbai, Oct 12 (UNI) Lupin announced that it has received Euro 20 million from Laboratories Servier of France for the sale of additional patent rights for Perindopril.
Lupin
Managing
Director
Dr
Kamal
K
Sharma
said,
''This
income
significantly
boosts
our
performance
for
the
current
year.
We
are
very
pleased
with
the
transaction
and
it
goes
a
long
way
to
further
demonstrate
our
IP
capabilities.''
UNI
Comments
Story first published: Saturday, October 13, 2007, 12:50 [IST]